Anatomic or functional asplenia (including sickle cell disease), HIV infection, persistent complement component deficiency, complement inhibitor (e.g., eculizumab, ravulizumab) use: Travel in countries with hyperendemic or epidemic meningococcal disease, including countries in the African meningitis belt or during the Hajj: First-year college students who live in residential housing (if not previously vaccinated at age 16 years or older) or military recruits: Adolescent vaccination of children who received MenACWY prior to age 10 years: Note: Menactra should be administered either before or at the same time as DTaP. Vaccination Schedule This vaccine is recommended for use as early as 3 months of age or older. s/c or i/m depending on the vaccine. Age 13–15 years: 1 dose now and booster at age 16–18 years (minimum interval: 8 weeks), Dose 1 at age 8 weeks: 4-dose series at 2, 4, 6, 12 months, Dose 1 at age 7–23 months: 2-dose series (dose 2 at least 12 weeks after dose 1 and after age 12 months), Dose 1 at age 24 months or older: 2-dose series at least 8 weeks apart, Age 9–23 months: 2-dose series at least 12 weeks apart, Age 24 months or older: 2-dose series at least 8 weeks apart, Dose 1 at 8 weeks: 4-dose series at 2, 4, 6, 12 months, Dose 1 at 7–23 months: 2-dose series (dose 2 at least 12 weeks after dose 1 and after age 12 months), 2-dose series (dose 2 at least 12 weeks after dose 1; dose 2 may be administered as early as 8 weeks after dose 1 in travelers), 1 dose for healthy children age 24–59 months with any incomplete* PCV13 series, 3 PCV13 doses: 1 dose PCV13 (at least 8 weeks after any prior PCV13 dose), Less than 3 PCV13 doses: 2 doses PCV13 (8 weeks after the most recent dose and administered 8 weeks apart), No history of PPSV23: 1 dose PPSV23 (at least 8 weeks after any prior PCV13 dose), No history of either PCV13 or PPSV23: 1 dose PCV13, 1 dose PPSV23 at least 8 weeks later, Any PCV13 but no PPSV23: 1 dose PPSV23 at least 8 weeks after the most recent dose of PCV13, PPSV23 but no PCV13: 1 dose PCV13 at least 8 weeks after the most recent dose of PPSV23, No history of PPSV23: 1 dose PPSV23 (at least 8 weeks after any prior PCV13 dose) and a 2nd dose of PPSV23 5 years later, No history of either PCV13 or PPSV23: 1 dose PCV13, 2 doses PPSV23 (dose 1 of PPSV23 administered 8 weeks after PCV13 and dose 2 of PPSV23 administered at least 5 years after dose 1 of PPSV23), Any PCV13 but no PPSV23: 2 doses PPSV23 (dose 1 of PPSV23 administered 8 weeks after the most recent dose of PCV13 and dose 2 of PPSV23 administered at least 5 years after dose 1 of PPSV23), PPSV23 but no PCV13: 1 dose PCV13 at least 8 weeks after the most recent PPSV23 dose and a 2nd dose of PPSV23 administered 5 years after dose 1 of PPSV23 and at least 8 weeks after a dose of PCV13. Composition : Each dose of vaccine contains:-PPR75/1 (EMVY strain)... 10^2.5 DICC50 Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. dogs. Hemorrhagic Septicaemia. However, a dose is still recommended at or after age 4 years and at least 6 months after the previous dose. The repeat dose should be spaced after the invalid dose by the recommended minimum interval. It contains not less than 10 2.5 TCID 50 per d1 ml dose .The diluent is used to re-hydrate the freeze-dried component. Says Yadav, "This is a successful venture involving only a Rs 40-lakh investment." Adolescents 18 years and older may receive the combined HepA and HepB vaccine. Foot and mouth disease. COMPOSITION PESTEVAX TM is a freeze-dried live attenuated PPR virus vaccine prepared from the Nigerian strain 75/1. A vaccine is used where the disease is established and it provides good immunity. (Use combination vaccines instead of separate injections when appropriate). Dose 5 is not necessary if dose 4 was administered at age 4 years or older and at least 6 months after dose 3. For further details, see, Information on travel vaccine requirements and recommendations is available at, For vaccination of persons with immunodeficiencies, see. These are the common vaccination schedule for sheep. Immunization Schedule Immunization Schedules. In 2015, FAO and OIE launched a global eradication program (GCSE) based on vaccination campaigns. You will be subject to the destination website's privacy policy when you follow the link. 4. Series containing oral polio vaccine (OPV), either mixed OPV-IPV or OPV-only series: *Fully vaccinated = 5 valid doses of DTaP OR 4 valid doses of DTaP if dose 4 was administered at age 4 years or older. Dose 2 may be administered as early as 4 weeks after dose 1. 3-4 months,, repeat annually. Age 15 years or older at initial vaccination: 3-dose series at 0, 1–2 months, 6 months (minimum intervals: dose 1 to dose 2: 4 weeks / dose 2 to dose 3: 12 weeks / dose 1 to dose 3: 5 months; repeat dose if administered too soon) If completed valid vaccination series with any HPV vaccine, no additional doses needed. See Tables 8, 9, and 11 in the ACIP pneumococcal vaccine recommendations pdf[24 pages] for complete schedule details. Do not restart or add doses to vaccine series for extended intervals between doses. PPR brainstorming meeting (Nepal, 13-14 April 2016) 5 / 28 Southern Ghana: participatory disease searching No PPR suspicion PPR suspicion No vaccination Vaccine alone Vaccine with support Vaccine with support & dewormer 8 7 6 5 0 −3 −2 −1 100 km 0 200 1 PPR brainstorming meeting (Nepal, 13-14 April 2016) 6 / 28 For calculating intervals between doses, 4 weeks = 28 days. Vaccine diluents vials of 50 ml or 100 ml … First two doses before august. Diphtheria, tetanus, & acellular pertussis, Tetanus, diphtheria, & acellular pertussis, General Best Practice Guidelines for Immunization, www.hrsa.gov/vaccinecompensation/index.html, ACIP pneumococcal vaccine recommendations, Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States, Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Outbreak information (including case identification and outbreak response), see Manual for the Surveillance of Vaccine-Preventable Diseases, National Center for Immunization and Respiratory Diseases, Schedule for Infants and Children (birth-6 years), Schedule for Preteens and Teens (7 years – 18 years), U.S. Department of Health & Human Services, Consult relevant ACIP statements for detailed, For information on contraindications and precautions for the use of a vaccine, consult the. PPR-VAC™ Freeze - dried modified virus vaccine against Peste des Petits Ruminants. Study population. 4 or more doses of IPV can be administered before age 4 years when a combination vaccine containing IPV is used. Use any influenza vaccine appropriate for age and health status annually: 2 doses, separated by at least 4 weeks, for. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. See. If HepB series is delayed, test 1–2 months after final dose. In the first 6 months of life, use minimum ages and intervals only for travel to a polio-endemic region or during an outbreak. Thus vaccination play a very important role for keeping your goats healthy, growing, productive and diseases free. After reconstitution with respective diluents each dose of 1 ml contains not less than 2.5 TCID 50 PPR virus. Vaccination Schedule. What is the public health risk associated with this disease? The district is frequently affected by PPR outbreaks and annual vaccination typically takes place between September and December to prevent disease outbreaks that are usually expected to occur after December when there is more mixing of animals in the grazing fields after harvesting crops. For vaccine recommendations for persons 19 years of age or older, see the Recommended Adult Immunization Schedule. Lyme. Vaccines … Vaccination Methods The vaccine is presented as freeze dried preparation in vials. CDC official immunization schedules for children, preteens, teens, and adults for health care professionals, parents, and the general public. IPV is not routinely recommended for U.S. residents 18 years and older. Vaccines in the Child and Adolescent Immunization Schedule. Disease Started series at age 9 through 14 years, except immunocompromised persons 2 0, 6 to 12 months 5 months between doses Started series at age 15 through 26 years, and immunocompromised persons (any age) 3 0, 1 to 2, 6 months 4 weeks between doses 1-2 12 weeks between doses 2-3 5 months between doses 1-3. The maximum age for use of MMRV is 12 years.